Skip to main content
Premium Trial:

Request an Annual Quote

GE Taps Former Affymetrix President Siegel to Lead Healthymagination

NEW YORK (GenomeWeb News) – GE today said that it has named Sue Siegel, a former president of Affymetrix, to serve as CEO of its healthymagination initiative.

Siegel joins GE from Mohr Davidow Ventures, where she was a general partner leading investments in technology paltforms such as molecular diagnostics and digital health. She takes over the CEO role from Mike Barber, who led the initiative since 2009 but has been named VP and general manager of molecular imaging at GE Healthcare.

Healthymagination is a $6 billion commitment launched by GE in 2009 and aimed at lowering the costs of healthcare while increasing access. Part of the initiative is the GE healthymagination Fund, which also was launched in 2009 with $250 million and is focused on funding startups that are developing or offering life sciences tools, diagnostics, and health care information technologies. Among the firms that have already received support through the fund are molecular diagnostics firm CardioDx and NanoString Technologies.

"As we continue to work with our partners to revolutionize health, we need a leader to connect GE with new healthcare businesses, thought leaders, and governments as we seek new models of healthcare delivery and innovation, across GE and the globe," GE Chairman and CEO Jeff Immelt, said in a statement. "Sue is the right leader at the right time for healthymagination."

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.